Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 05.02.2025
Nagarro SE
Munich, February 5, 2025 – The Management Board of Nagarro SE, Munich (the “Company”), has decided today to again make use of the authorization pursuant to Sec. 71 para. 1 no. 8 of the German Stock Corporation Act (Aktiengesetz, AktG) to repurchase shares of the Company, which was granted by the shareholders’ meeting of October 30, 2020.
In aggreg [ … ]
Wed, 05.02.2025
The NAGA Group AG
NAGA Group AG broadly in line with expectations in 2024 financial year
Hamburg, 5 February 2025 – The NAGA Group AG (XETRA: N4G, ISIN: DE000A161NR7), provider of the all-in-one financial SuperApp NAGA, closed the past financial year 2024 broadly in line with its own expectations according to preliminary figures. Business activities revolved around [ … ]
Wed, 05.02.2025
Kallang Alive Sport Management
EQS Newswire / 05/02/2025 / 11:14 CET/CEST
Close to 22,000 tennis fans flocked to Kallang Tennis Hub across nine days Second-seed Elise Mertens bested Ann Li to claim her 9th career WTA singles title Desirae Krawczyk and Giuliana Olmos claimed victory in a thrilling Doubles Final SINGAPORE - Media OutReach Newswire [ … ]
Wed, 05.02.2025
Viromed Medical AG
Viromed Medical AG: Successful placement of shares with a strategic investor in the healthcare industry to accelerate market entry in Europe
Pinneberg, 5 February 2025 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) was informed by its majority shareholder (together with his wife) and CEO Uwe Perbandt about the off-market placement of a tot [ … ]
Wed, 05.02.2025
NORMA Group SE
NORMA Group receives major order for tank ventilation line systems
Contract worth around EUR 140 million
Line systems prevent evaporative emissions from gasoline entering the environment
Maintal, Germany, February 5, 2025 – NORMA Group has won a major order for tank ventilation systems. From mid-2026 to 2035, the company will supply a well-kno [ … ]
Wed, 05.02.2025
DEBRA Research GmbH
DEBRA Research and LEO Pharma Announce Strategic Partnership to Advance Treatments for Rare Skin Diseases
Partners form non-exclusive collaboration to expand research efforts and develop new treatments for Epidermolysis Bullosa (EB).
The partnership leverages DEBRA Research’s focus on patient care and pharma experience and LEO Pharma’s extensive [ … ]
Wed, 05.02.2025
Bechtle AG
Bechtle announces preliminary figures for FY 2024
Business volume climbs by approximately 2% to around €8 bn
EBT margin at 5.5%
Key financial metrics in line with expectations
Neckarsulm, 5 February 2025 – Based on preliminary figures, Bechtle AG has been able to reconcile its 2024 financial results with capital market expectations. Busine [ … ]
Wed, 05.02.2025
Swiss Prime Site Solutions
Swiss Prime Site Solutions
/ Key word(s): Capital Increase
Capital increase for Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) in March 2025 05.02.2025 / 08:00 CET/CEST
Press Release
The SPSS IFC can look back on a successful 2023/2024 financial year (1.10.2023–30.9.2024). All strategic targets were met and s [ … ]
Wed, 05.02.2025
Gurit Holding AG
Gurit Holding AG
/ Key word(s): ESG
GURIT AWARDED ECOVADIS GOLD MEDAL FOR SUSTAINABILITY COMMITMENT AND PERFORMANCE
05.02.2025 / 06:45 CET/CEST
Zurich, February 5, 2025
Gurit (SIX Swiss Exchange: GURN) is pleased to announce that it has, for a second time, been awarded the Gold Medal by EcoVadis, a global leader in bus [ … ]
Wed, 05.02.2025
Formycon AG
Press Release // February 05, 2025
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Planegg-Martinsried, Germany – Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global commercialization rights of FYB203/AHZANTIVE®1 (aflibercept [ … ]